LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.89
+0.10 (1.73%)
At close: Jul 2, 2026, 4:00 PM EDT
5.90
+0.01 (0.17%)
After-hours: Jul 2, 2026, 6:55 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $184.68 million as of July 2, 2026. Its market cap has decreased by -77.34% in one year.
Market Cap
184.68M
Enterprise Value
-73.03M
1-Year Change
-77.34%
Ranking
Category
Stock Price
$5.89
Market Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $184.68M, a decrease of -55.35%. That is a compound annual growth rate of -29.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 184.68M | -63.11% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 197.90M |
| Tonix Pharmaceuticals Holding | 196.71M |
| MediWound | 194.90M |
| Humacyte | 191.44M |
| Oramed Pharmaceuticals | 188.26M |
| Protalix BioTherapeutics | 186.93M |
| OnKure Therapeutics | 185.82M |
| Equillium | 183.99M |